Literature DB >> 3655673

Reduction of adverse drug reactions by computerized drug interaction screening.

K W Davidson1, A Kahn, R D Price.   

Abstract

Computerized drug-interaction screening systems (CDISS) have been developed as a tool to help decrease the enormous morbidity and expense related to adverse drug interactions. In previous studies the CDISS was used primarily by pharmacists in hospital settings to screen for interactions after the prescription had been written. This study tests the feasibility of family physicians using CDISS before writing the prescription to allow for changes in the prescription while the patient is still in the office. In a 30-day period, 103 patients were screened by family physicians for potential drug-drug, drug-alcohol, and drug-food interactions. Potential drug interactions of varying clinical significance were detected for 71 patients (68.9 percent). The prescription plan was changed for 16 patients (15.5 percent) as a result of using the CDISS. Participating physicians reported that they gained new information in 45.8 percent of the patient encounters, that their awareness of the potential for drug interactions was heightened by participation in this study, and that their exposure to the CDISS was worthwhile as an educational tool. While a few problems, mainly logistic, were noted with the CDISS as used in this study, the authors conclude that with modifications a CDISS can be of great educational and clinical value to the family physician and his or her patients.

Entities:  

Mesh:

Year:  1987        PMID: 3655673

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  4 in total

1.  Smart Pharmacy Cards to automate patient records for prospective drug utilization review.

Authors:  P J Ognibene
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

2.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

Authors:  Laurence Guédon-Moreau; Dominique Ducrocq; Marie-Francoise Duc; Yves Quieureux; Catherine L'Hôte; Jean Deligne; Jacques Caron
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

3.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

Authors:  Laurence Guédon-Moreau; Dominique Ducrocq; Marie-Francoise Duc; Yves Quieureux; Catherine L'Hôte; Jean Deligne; Jacques Caron
Journal:  Eur J Clin Pharmacol       Date:  2003-10-14       Impact factor: 2.953

4.  Potential identifiability and preventability of adverse events using information systems.

Authors:  D W Bates; A C O'Neil; D Boyle; J Teich; G M Chertow; A L Komaroff; T A Brennan
Journal:  J Am Med Inform Assoc       Date:  1994 Sep-Oct       Impact factor: 4.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.